Bill Wexler's Dog Pound Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound

REFR 1.380

-5.5%

Dec 23 3:55 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Larry Brubaker who wrote (6117)	1/15/2000 10:53:00 PM
From: Mike M	of 10293

Sure it is...for anyone who wants to keep the cold an additional week and pay another $40 to 90 plus doctor visit for the privilege. If you like the reaction to this drug wait until GUMM's clinical is released. We will see if there is any cold market left for pleconaril. The company wants to get the drug approved first for viral meningitis, but it is the common cold that is likely to be the medicine's biggest market. This drug isn't even close to commercial use for the common cold and my bet is that market never can be truly significant. It is popular to bury GUMM around here, but you might want to stick to what you know Larry...floorless convertibles isn't it?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next